Hepatitis Monthly

Published by: Kowsar

Efficacy of Hepatitis B Vaccination in Under Five-Year-Old Children in Iran: A Systematic Review and Meta-Analysis Study

Fatemeh Najafi 1 , Kourosh Sayehmiri 2 , * and Reza Najafi 3
Authors Information
1 PhD Student of Nursing, Department of Internal- Surgical Nursing , School of Nursing and Midwifery, Tehran University of Medical Sciences, Tehran, Iran
2 Health Faculty, Biostatistics Department, Ilam University of Medical Sciences, Ilam, Iran
3 Pediatric Endocrinology Department, Ilam University of Medical Sciences, Ilam, Iran
Article information
  • Hepatitis Monthly: June 2018, 18 (6); e65385
  • Published Online: May 14, 2018
  • Article Type: Review Article
  • Received: December 21, 2017
  • Revised: April 22, 2018
  • Accepted: April 23, 2018
  • DOI: 10.5812/hepatmon.65385

To Cite: Najafi F, Sayehmiri K, Najafi R. Efficacy of Hepatitis B Vaccination in Under Five-Year-Old Children in Iran: A Systematic Review and Meta-Analysis Study, Hepat Mon. 2018 ;18(6):e65385. doi: 10.5812/hepatmon.65385.

Abstract
Copyright © 2018, Hepatitis Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Context
2. Objective
3. Data Sources
4. Study Selection
5. Data Extraction
6. Results
7. Conclusions
References
  • 1. Trepo C, Chan HL, Lok A. Hepatitis B virus infection. Lancet. 2014;384(9959):2053-63. doi: 10.1016/S0140-6736(14)60220-8. [PubMed: 24954675].
  • 2. Ding X, Yang Y, Han B, Du C, Xu N, Huang H, et al. Transcriptomic characterization of hepatocellular carcinoma with CTNNB1 mutation. PLoS One. 2014;9(5). e95307. doi: 10.1371/journal.pone.0095307. [PubMed: 24798046]. [PubMed Central: PMC4010419].
  • 3. Rukunuzzaman M, Karim MB. Chronic Hepatitis B in Children - A Review. Mymensingh Med J. 2015;24(3):649-56. [PubMed: 26329971].
  • 4. Daniels D, Grytdal S, Wasley A, Centers for Disease C.Prevention. Surveillance for acute viral hepatitis - United States, 2007. MMWR Surveill Summ. 2009;58(3):1-27. [PubMed: 19478727].
  • 5. Mohammadi Z, Keshtkar A, Eghtesad S, Jeddian A, Pourfatholah AA, Maghsudlu M, et al. Epidemiological Profile of Hepatitis B Virus Infection in Iran in the Past 25 years; A Systematic Review and Meta-analysis of General Population Studies. Middle East J Dig Dis. 2016;8(1):5-18. doi: 10.15171/mejdd.2016.01. [PubMed: 26933476]. [PubMed Central: PMC4773083].
  • 6. Azarkar Z. [Efficacy of hepatitis-B vaccine in children from 12 to 16 months in Mashad health centers]. J Qazvin Univ of Med Sci. 2004;(29):38-41. Persian.
  • 7. World Health Organization. Expanded programme on immunisation Report of 14th Global Advisory Group. Geneva: WHO; 1991.
  • 8. Rezaee R, Aghcheli B, Poortahmasebi V, Qorbani M, Alavian SM, Jazayeri SM. Prevalence of National Responsiveness to HBV Vaccine After 22 Years of Iranian Expanded Program on Immunization (EPI): A Systematic Review and Meta-Analysis Study. Hepat Mon. 2015;15(5). e23618. doi: 10.5812/hepatmon.15(04)2015.23618. [PubMed: 26045701]. [PubMed Central: PMC4451270].
  • 9. Rafizadeh B, Kazemi AN, Amir Moghaddami HR, Mousavinasab M. [Survey of Anti-HBs Serum level in vaccinated 7-9 year-old children in Zanjan City 2004]. Zanjan Univ Med Sci. 2004;12(47):49-55. Persian.
  • 10. Fisman DN, Agrawal D, Leder K. The effect of age on immunologic response to recombinant hepatitis B vaccine: a meta-analysis. Clin Infect Dis. 2002;35(11):1368-75. doi: 10.1086/344271. [PubMed: 12439800].
  • 11. Jafarzadeh A, Rashidi-Nejad H, Hassanshahi G, Montazerifar J, Mozafari A, Nejad-Ghaderi M. [Evaluation of Serum Anti-Hbs Concentration in Children Vaccinated with Recombinant Hepatitis B Vaccine at Birth]. J Shahid Sadoughi Univ Med Sci. 2006;14(2):23-8. Persian.
  • 12. Azami M, Hafezi Ahmadi MR, Sayehmiri K. Hepatitis B vaccination efficacy in Iranian healthcare workers: A meta-analysis study. Hepat Mon. 2016;17(1). doi: 10.5812/hepatmon.37781.
  • 13. Schonberger K, Riedel C, Ruckinger S, Mansmann U, Jilg W, Kries RV. Determinants of Long-term protection after hepatitis B vaccination in infancy: a meta-analysis. Pediatr Infect Dis J. 2013;32(4):307-13. doi: 10.1097/INF.0b013e31827bd1b0. [PubMed: 23249904].
  • 14. Moradi AAV, Khoda Bakhsi B, Ghaemi EA, Mansourian AR, Sari Khani AAJ, Saeidi M. [The response rate to hepatitis B vaccination in children younger than one year of Gorgan]. J Gorgan Univ Med Sci. 2008;10(2):50-3. Persian.
  • 15. Tazhibi M, Hajivandi A, Tafti AD, Fallahzadeh H. The efficacy of hepatitis B vaccine in Iranian population: A systematic review and meta-analysis. J Educ Health Promot. 2014;3:53. doi: 10.4103/2277-9531.134741. [PubMed: 25077146]. [PubMed Central: PMC4114169].
  • 16. Ahmadi M, Moosavi SM, Jahanfar F. [Comparison of antibody level in post hepatitis B vaccination in children with 12-15 and 21-24 months age]. J Gorgan Univ Med Sci. 2012;4(2):59–65. Persian.
  • 17. Salehi M, Saneimoghadam E, Khosravi S. Evaluation of immune response of hepatitis B vaccination in Zahedan infants. Zahedan J Res Med Sci. 2002;4:155–8.
  • 18. Shokri F, Jafarzadeh A. High seroprotection rate induced by low doses of a recombinant hepatitis B vaccine in healthy Iranian neonates. Vaccine. 2001;19(31):4544-8. [PubMed: 11483282].
  • 19. Rostami N, Ghaffari V, Samaie H. Comparison of immune response to hepatitis B vaccine between term and preterm infants at birth. Arch Clin Infect Dis. 2006;7(1):11-4.
  • 20. Rezaei M, Nooripoor S, Ghorbani R, Ramezanshams F, Mamishi S, Mahmoudi S. Seroprotection after hepatitis B vaccination in children aged 1 to 15 years in central province of Iran, Semnan. J Prev Med Hyg. 2014;55(1):1-3. [PubMed: 25916024]. [PubMed Central: PMC4718339].
  • 21. Hosseini SM, Ranjbar R, Abolghasemi H, Turkaman M. Evaluation of the level of HBV antibody titer after HBV vaccination among children in Tehran, Iran. Hepat Mon. 2009;9(2):150-3.
  • 22. Jafarzadeh A, Khoshnoodi J, Ghorbani S, Hazrati SM, Mazaheri BF, Shokri F. Differential immunogenicity of a recombinant hepatitis b vaccine in Iranian neonates: Influence of ethnicity and environmental factors. Int J Infect. 2004;1(2):98-104.
  • 23. Zamani A, Shajari H, Sedighy I. Study on the ef ficacy of recombinant hepatitis B vaccine in Iranian infants. Med J Islamic Repub Iran. 2001;14(4):347-9.
  • 24. Dahifar H. Immunogenicity of Cuban hepatitis B vaccine in Iranian children. Arch Iranian Med. 2004;7(2):89-92.
  • 25. ul Haq N, Hassali MA, Shafie AA, Saleem F, Farooqui M, Aljadhey H. A cross sectional assessment of knowledge, attitude and practice towards Hepatitis B among healthy population of Quetta, Pakistan. BMC Public Health. 2012;12:692. doi: 10.1186/1471-2458-12-692. [PubMed: 22917489]. [PubMed Central: PMC3490724].
  • 26. Paganelli M, Stephenne X, Sokal EM. Chronic hepatitis B in children and adolescents. J Hepatol. 2012;57(4):885-96. doi: 10.1016/j.jhep.2012.03.036. [PubMed: 22634122].
  • 27. Yen YH, Chen CH, Wang JH, Lee CM, Changchien CS, Lu SN. Study of hepatitis B (HB) vaccine non-responsiveness among health care workers from an endemic area (Taiwan). Liver Int. 2005;25(6):1162-8. doi: 10.1111/j.1478-3231.2005.01157.x. [PubMed: 16343067].
  • 28. de la Hoz F, Perez L, de Neira M, Hall AJ. Eight years of hepatitis B vaccination in Colombia with a recombinant vaccine: factors influencing hepatitis B virus infection and effectiveness. Int J Infect Dis. 2008;12(2):183-9. doi: 10.1016/j.ijid.2007.06.010. [PubMed: 17913535].
  • 29. Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, et al. Evaluation of the impact of hepatitis B vaccination among children born during 1992-2005 in China. J Infect Dis. 2009;200(1):39-47. doi: 10.1086/599332. [PubMed: 19469708].
  • 30. Poorolajal J, Mahmoodi M, Majdzadeh R, Nasseri-Moghaddam S, Haghdoost A, Fotouhi A. Long-term protection provided by hepatitis B vaccine and need for booster dose: a meta-analysis. Vaccine. 2010;28(3):623-31. doi: 10.1016/j.vaccine.2009.10.068. [PubMed: 19887132].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments